XML 77 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Restatement of Previously Issued Unaudited Condensed Financial Statements - Statements of Cash Flows (Details) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2022
Jun. 30, 2022
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:          
Net loss $ (5,234,063) $ (11,170,449) $ (17,602,400) $ (25,328,567) $ (14,487,132)
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock-based compensation expense 3,434,944 5,338,705 7,694,716 9,152,520 4,697,627
Changes in operating assets and liabilities:          
Prepaid expenses and other current assets (1,113,278) (3,677,503) (4,815,873) (7,328,912) (270,788)
Accounts payable 240,923   1,157,631 3,273,180 346,218
Accrued expenses (350,315)   (137,610) 2,918,845 581,916
Net cash used in operating activities (3,021,789) (9,716,376) (13,703,536) (17,312,934) (9,132,159)
Cash flows from financing activities:          
Proceeds from issuance of common stock, net of issuance costs         46,648,413
Proceeds from exercise of stock options 4,613 4,613 4,613 4,613 95,102
Net cash provided by financing activities 4,613 4,613 4,613 4,613 46,743,515
Net (decrease) increase in cash and cash equivalents (3,017,176) (9,711,763) (13,698,923) (17,308,321) 37,611,356
Cash and cash equivalents, beginning of year 45,686,014 45,686,014 45,686,014 45,686,014 8,074,658
Cash and cash equivalents, end of year 42,668,838 35,974,251 31,987,091 28,377,693 45,686,014
As Reported          
Cash flows from operating activities:          
Net loss (5,894,213) (14,612,344) (22,233,790)    
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock-based compensation expense 3,434,944 5,338,705 7,694,716    
Changes in operating assets and liabilities:          
Prepaid expenses and other current assets (312,438) (235,608) (184,483)    
Accounts payable 240,923 213,767 1,157,631    
Accrued expenses (491,005) (420,896) (137,610)    
Net cash used in operating activities (3,021,789) (9,716,376) (13,703,536)    
Cash flows from financing activities:          
Proceeds from exercise of stock options 4,613 4,613 4,613    
Net cash provided by financing activities 4,613 4,613 4,613    
Net (decrease) increase in cash and cash equivalents (3,017,176) (9,711,763) (13,698,923)    
Cash and cash equivalents, beginning of year 45,686,014 45,686,014 45,686,014 $ 45,686,014  
Cash and cash equivalents, end of year 42,668,838 35,974,251 31,987,091   $ 45,686,014
Restatement Impacts          
Cash flows from operating activities:          
Net loss 660,150 3,441,895 4,631,390    
Changes in operating assets and liabilities:          
Prepaid expenses and other current assets (800,840) (3,441,895) $ (4,631,390)    
Accounts payable   213,767      
Accrued expenses $ 140,690 $ (420,896)